SYNGENEHealthcare Research, Analytics & Technology
Syngene International Ltd — Profit & Loss Statement
₹389.90
-1.04%
Syngene International Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net Income From Continuing And Discontinued Operation | 496.20 Cr | 510.00 Cr | 464.40 Cr | 395.80 Cr |
| Total Expenses | 2.90K Cr | 2.72K Cr | 2.46K Cr | 2.07K Cr |
| Rent Expense Supplemental | 6.10 Cr | 5.50 Cr | 4.40 Cr | 4.80 Cr |
| Diluted Average Shares | 40.23 Cr | 40.20 Cr | 40.36 Cr | 40.29 Cr |
| Basic Average Shares | 40.19 Cr | 40.14 Cr | 40.07 Cr | 39.81 Cr |
| Diluted EPS | 12.34 | 12.69 | 11.51 | 9.82 |
| Basic EPS | 12.35 | 12.71 | 11.59 | 9.94 |
| Diluted NI Availto Com Stockholders | 496.20 Cr | 510.00 Cr | 464.40 Cr | 395.80 Cr |
| Net Income Common Stockholders | 496.20 Cr | 510.00 Cr | 464.40 Cr | 395.80 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 496.20 Cr | 510.00 Cr | 464.40 Cr | 395.80 Cr |
| Minority Interests | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Including Noncontrolling Interests | 496.20 Cr | 510.00 Cr | 464.40 Cr | 395.80 Cr |
| Net Income Continuous Operations | 496.20 Cr | 510.00 Cr | 464.40 Cr | 395.80 Cr |
| Tax Provision | 163.70 Cr | 110.80 Cr | 129.20 Cr | 88.60 Cr |
| Pretax Income | 659.90 Cr | 620.80 Cr | 593.60 Cr | 484.40 Cr |
| Other Non Operating Income Expenses | 71.80 Cr | 0.10 Cr | 70.90 Cr | 52.80 Cr |
| Special Income Charges | 29.60 Cr | -14.20 Cr | -8.50 Cr | -33.50 Cr |
| Other Special Charges | -32.60 Cr | 2.50 Cr | 7.50 Cr | 32.70 Cr |
| Write Off | 3.00 Cr | 0.60 Cr | 1.00 Cr | 0.80 Cr |
| Net Non Operating Interest Income Expense | 6.70 Cr | 30.90 Cr | 25.80 Cr | 29.00 Cr |
| Interest Expense Non Operating | 49.20 Cr | 45.10 Cr | 34.50 Cr | 17.50 Cr |
| Interest Income Non Operating | 55.90 Cr | 76.00 Cr | 60.30 Cr | 46.50 Cr |
| Operating Income | 613.50 Cr | 647.10 Cr | 618.20 Cr | 434.40 Cr |
| Operating Expense | 1.96K Cr | 1.79K Cr | 1.60K Cr | 1.32K Cr |
| Other Operating Expenses | 461.80 Cr | 414.80 Cr | 372.70 Cr | 292.20 Cr |
| Depreciation And Amortization In Income Statement | 432.60 Cr | 425.90 Cr | 366.50 Cr | 309.70 Cr |
| Amortization | 8.90 Cr | 7.90 Cr | 5.80 Cr | 6.70 Cr |
| Depreciation Income Statement | 423.70 Cr | 418.00 Cr | 360.70 Cr | 303.00 Cr |
| Selling General And Administration | 192.30 Cr | 169.70 Cr | 123.60 Cr | 91.00 Cr |
| Selling And Marketing Expense | 22.70 Cr | 20.30 Cr | 18.50 Cr | 11.70 Cr |
| General And Administrative Expense | 169.60 Cr | 149.40 Cr | 105.10 Cr | 79.30 Cr |
| Rent And Landing Fees | 6.10 Cr | 5.50 Cr | 4.40 Cr | 4.80 Cr |
| Gross Profit | 2.57K Cr | 2.44K Cr | 2.22K Cr | 1.76K Cr |
| Cost Of Revenue | 942.50 Cr | 930.20 Cr | 860.20 Cr | 749.00 Cr |
| Total Revenue | 3.51K Cr | 3.37K Cr | 3.08K Cr | 2.51K Cr |
| Operating Revenue | 3.51K Cr | 3.37K Cr | 3.08K Cr | 2.51K Cr |
| Tax Effect Of Unusual Items | 11.29 Cr | 0.04 Cr | 0.46 Cr | -4.98 Cr |
| Tax Rate For Calcs | 0.25 | 0.18 | 0.22 | 0.18 |
| Normalized EBITDA | 1.10K Cr | 1.09K Cr | 992.50 Cr | 838.80 Cr |
| Total Unusual Items | 45.50 Cr | 0.20 Cr | 2.10 Cr | -27.20 Cr |
| Total Unusual Items Excluding Goodwill | 45.50 Cr | 0.20 Cr | 2.10 Cr | -27.20 Cr |
| Net Income From Continuing Operation Net Minority Interest | 496.20 Cr | 510.00 Cr | 464.40 Cr | 395.80 Cr |
| Reconciled Depreciation | 432.60 Cr | 425.90 Cr | 366.50 Cr | 309.70 Cr |
| Reconciled Cost Of Revenue | 942.50 Cr | 930.20 Cr | 860.20 Cr | 749.00 Cr |
| EBITDA | 1.14K Cr | 1.09K Cr | 994.60 Cr | 811.60 Cr |
| EBIT | 709.10 Cr | 665.90 Cr | 628.10 Cr | 501.90 Cr |
| Net Interest Income | 6.70 Cr | 30.90 Cr | 25.80 Cr | 29.00 Cr |
| Interest Expense | 49.20 Cr | 45.10 Cr | 34.50 Cr | 17.50 Cr |
| Interest Income | 55.90 Cr | 76.00 Cr | 60.30 Cr | 46.50 Cr |
| Normalized Income | 461.99 Cr | 509.84 Cr | 462.76 Cr | 418.02 Cr |
| Restructuring And Mergern Acquisition | — | 11.10 Cr | — | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Syngene International Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.